Tevano Systems Holdings Inc. (TEVNF)
USD 0.0
(-99.76%)
USD 0.0
(-99.76%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | - CAD | 100.0% |
| 2022 | -4.76 Million CAD | 16.51% |
| 2021 | -5.7 Million CAD | -17655.92% |
| 2020 | -32.14 Thousand CAD | 49.93% |
| 2019 | -64.19 Thousand CAD | 76.58% |
| 2018 | -274.05 Thousand CAD | 56.94% |
| 2017 | -636.46 Thousand CAD | 45.25% |
| 2016 | -1.16 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | - CAD | 0.0% |
| 2023 Q2 | -181.22 Thousand CAD | 44.57% |
| 2023 Q1 | -326.94 Thousand CAD | 26.43% |
| 2023 FY | - CAD | 100.0% |
| 2023 Q3 | -455.32 Thousand CAD | -151.24% |
| 2023 Q4 | - CAD | 100.0% |
| 2022 Q3 | -706.43 Thousand CAD | 73.8% |
| 2022 Q1 | -916.99 Thousand CAD | 70.69% |
| 2022 FY | -4.76 Million CAD | 16.51% |
| 2022 Q4 | -444.37 Thousand CAD | 37.1% |
| 2022 Q2 | -2.69 Million CAD | -194.07% |
| 2021 Q1 | -326.59 Thousand CAD | 0.0% |
| 2021 FY | -5.7 Million CAD | -17655.92% |
| 2021 Q3 | -1.5 Million CAD | 0.0% |
| 2021 Q4 | -3.12 Million CAD | -107.93% |
| 2020 FY | -32.14 Thousand CAD | 49.93% |
| 2020 Q3 | -258.86 Thousand CAD | 0.0% |
| 2019 FY | -64.19 Thousand CAD | 76.58% |
| 2018 FY | -274.05 Thousand CAD | 56.94% |
| 2017 FY | -636.46 Thousand CAD | 45.25% |
| 2016 FY | -1.16 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 100.0% |
| Ansell Limited | 129.3 Million USD | 100.0% |
| Ansell Limited | 129.3 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 31.13 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | -1.59 Million USD | 100.0% |
| Psykey, Inc. | -797.5 Thousand USD | 100.0% |
| ConvaTec Group Plc | 262.7 Million USD | 100.0% |
| ConvaTec Group Plc | 262.7 Million USD | 100.0% |
| Encision Inc. | -640.78 Thousand USD | 100.0% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 100.0% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 100.0% |
| Innovative MedTech Inc. | -4.27 Million USD | 100.0% |
| LifePoint, Inc. | -7.49 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | -122.89 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | -241.15 Million USD | 100.0% |
| Sector 10, Inc. | -39.84 Thousand USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.0% |
| SheerVision, Inc. | 155.72 Thousand USD | 100.0% |
| United Health Products, Inc. | -2.42 Million USD | 100.0% |
| Vasamed, Inc. | 4.74 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 100.0% |
| Yubo International Biotech Limited | -1.2 Million USD | 100.0% |